# The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today.

*business · news · 2026-04-12 · The Motley Fool Australia*

## Key points

- Telix and Regeneron entered a 50/50 global cost and profit-sharing agreement for radiopharmaceutical therapies.
- Telix receives a US$40 million upfront payment for four initial programs, with expansion options.
- The deal could yield up to US$2.1 billion in milestone payments plus royalties for Telix.
- Telix will lead commercialisation of diagnostic assets, with Regeneron receiving a share of profits.

**Companies:** Regeneron Pharmaceuticals, Telix Pharmaceuticals
**Countries:** Australia, United States

[Read the full story on The Motley Fool Australia](https://www.fool.com.au/2026/04/13/telix-pharmaceuticals-announces-us40m-regeneron-radiopharma-deal/)

---

Canonical: https://newsio.io/n/2af7357c-ec93-4715-a1f5-93ef682a0139/the-telix-pharmaceuticals-ltd-asx-tlx-share-price-is-in-focus-today
Summarized by Newsio from The Motley Fool Australia. https://newsio.io/how-it-works